
Why Am I Not Losing Weight on Ozempic? 9 Real Reasons and What to Ask Your Doctor
Not losing weight on Ozempic? The 9 real reasons, from starting doses to non-response, how to check each one, what to do, and when to talk to your doctor.
Written by Dr. Sheri Tomas. Updated October 24, 2026.
If you are not losing weight on Ozempic, the most likely reasons are that you are still on a starting dose, you have not been on it long enough, or your appetite has dropped but your calorie intake has not. Ozempic is a diabetes drug whose weight effect is real but modest and slow: in trials, people lost about 4 to 6 kg (9 to 13 lb) over 30 to 40 weeks, far less than the 15% headlines that come from its higher-dose sister drug Wegovy. Roughly one in seven people on semaglutide lose less than 5% of their body weight even when everything is done right.
This guide walks through the nine reasons the scale stalls, how to tell which one applies to you, what to do about each, and the questions to bring to your doctor if nothing changes after four months on a full dose.
Not Losing Weight on Ozempic: The Short Answer
- 1The 0.25 mg and 0.5 mg doses are for getting your stomach used to the drug, not for weight loss. Most loss happens at 1 mg and 2 mg.
- 2Expect about 1% to 2% of body weight per month at a full dose; slower is common in people with type 2 diabetes.
- 3The usual fixes: give it 16 weeks at the maintenance dose, track what you actually eat for a week, cut liquid calories, add protein and walking, and check sleep and medications.
- 4About 14% of people in the trials lost under 5% of their weight. Non-response is real and has options.
- 5Compounded, counterfeit or badly stored semaglutide can simply be underdosed.
- 6Talk to your doctor if you have lost less than 5% after four months on at least 1 mg, or if weight loss has stopped for three months at the top dose.
How Much Weight Should You Lose on Ozempic?
Set the bar in the right place first. Ozempic is approved for type 2 diabetes, and its weight-loss data come from diabetes trials at 0.5 mg, 1 mg and 2 mg. Wegovy is the same molecule (semaglutide) at 2.4 mg, approved for weight management, and that is where the 15% figures come from. See is Ozempic approved for weight loss for the full distinction.
Typical weight loss with semaglutide in trials
Ozempic 1 mg
Adults with type 2 diabetes (SUSTAIN trials)
About 4.5 to 6.5 kg (10 to 14 lb)
30 to 56 weeks
Ozempic 2 mg
Adults with type 2 diabetes (SUSTAIN FORTE)
About 6.9 kg (15 lb)
40 weeks
Wegovy 2.4 mg
Adults with obesity, no diabetes (STEP 1)
14.9% of body weight (about 15 kg / 33 lb)
68 weeks
Wegovy 2.4 mg
Adults with obesity and type 2 diabetes (STEP 2)
9.6% of body weight
68 weeks
Two things stand out. People with diabetes lose less than people without it, even at the same dose. And Ozempic doses produce roughly a third to half of what Wegovy produces. If you are on Ozempic 0.5 mg and expecting Wegovy results, nothing is wrong with you; the comparison is wrong. For a week-by-week picture, see how long it takes for Ozempic to work.
9 Reasons You Are Not Losing Weight on Ozempic
Work through these in order. The first three explain most cases.
1. You Are Still on a Starting Dose
Ozempic begins at 0.25 mg for four weeks, then 0.5 mg for at least four weeks, before 1 mg and, if needed, 2 mg. The 0.25 mg dose is described in the label as a starting dose for tolerability that is not effective for glycemic control, and it does little for weight either. Many people spend two or three months on these low doses, see the scale barely move, and conclude the drug does not work. It has not really started yet.
What to do: check your pen. If you are on 0.25 mg or 0.5 mg, the honest answer is to wait. Ask your doctor about the timing of your next increase, and whether side effects are the reason you have stayed low.
2. You Have Not Given It Enough Time
Semaglutide builds up in the blood over four to five weeks at each dose, and the full appetite effect follows. In STEP 1, people had lost about 2% at week 4, 6% at week 12 and 10% at week 20; the fastest loss came between months three and six, after the dose had been raised. The Wegovy label tells doctors to judge response after 16 weeks on the full maintenance dose, not after 16 weeks on the drug.
What to do: count weeks from the day you reached 1 mg (or your maintenance dose), not from your first injection. Judge at 16 weeks.
3. Your Appetite Dropped but Your Calories Did Not
Ozempic works by making you feel full sooner and think about food less. It does not count calories for you. People commonly keep eating the same portions out of habit, finish the plate because it is there, or switch to small frequent snacks that add up. Liquid calories are the biggest blind spot: lattes, juice, smoothies, alcohol and sweetened drinks slide past the fullness signal, because the drug slows how fast solid food leaves the stomach much more than liquids.
What to do: track everything for seven days with an app or a notebook, including drinks. Most people find 300 to 500 calories a day they did not know about. Replace sweet drinks with water or unsweetened tea, and aim for a protein source at every meal, which keeps you fuller for longer and protects muscle.
4. You Are Drinking Alcohol Regularly
Alcohol adds calories, lowers inhibition around food, disrupts sleep and, for some people on GLP-1 drugs, hits harder than before. Three or four drinks a week can erase a week's deficit. Our guide to Ozempic and alcohol covers the interactions in detail.
What to do: try four alcohol-free weeks and compare the scale. Many people also find they want to drink less on semaglutide.
5. You Have Hit a Plateau
Weight loss on semaglutide is not a straight line. After an initial drop, the body adapts: a lighter body burns fewer calories, hunger hormones push back, and the appetite effect of the drug can soften after months at the same dose. In the trials, weight loss slowed sharply after about 60 weeks and flattened out. A plateau after losing 10% or more is a sign of a new set point, not failure.
What to do: a plateau after months of loss usually calls for a dose increase if you are not at 2 mg, more protein and resistance training to protect muscle, and a realistic look at whether your current weight is already a success. If you are at the top dose and have stalled for three months, that is a conversation with your doctor about alternatives such as Wegovy or Zepbound.
6. You Are Missing or Delaying Doses
Semaglutide needs weekly injections to keep steady levels. Skipping a dose drops the level by about half within a week; missing two in a row effectively resets you. People often miss doses because of supply problems, travel, or side effects they are trying to avoid. See what happens if you miss an Ozempic dose for the catch-up rules.
What to do: pick a fixed day, set a reminder, and keep a spare pen if your pharmacy allows. If you are delaying doses because of nausea, tell your doctor; a slower titration is better than an irregular one.
7. Other Medications or Conditions Are Working Against You
Several common drugs cause weight gain or block weight loss: insulin and sulfonylureas (glipizide, glimepiride), many antidepressants and antipsychotics, beta-blockers, steroids, some seizure medicines and some hormonal contraceptives. Conditions that slow weight loss include an underactive thyroid, polycystic ovary syndrome, sleep apnea, chronic stress and poor sleep. Menopause changes fat distribution and makes loss slower, too.
What to do: bring a full list of your medications to your doctor. If you have diabetes and are on insulin or a sulfonylurea, ask whether the dose can be reduced as your blood sugar improves; those two drugs are a very common reason that Ozempic patients lose less. Ask about a thyroid test and a sleep assessment if you snore or wake unrefreshed.
8. Your Semaglutide May Not Be What It Says
If you use compounded semaglutide, or bought it online, the dose may not be what the label claims. FDA has warned about compounded products with dosing errors, wrong salt forms and counterfeit Ozempic pens in the supply chain. Even genuine Ozempic loses potency if it is frozen or left in heat. See compounded semaglutide vs Ozempic and our storage guide.
What to do: if you have none of the usual effects at all, not even mild nausea or reduced appetite, after eight weeks at 0.5 mg or more, question the product before you question yourself. Pharmacy-dispensed brand-name Ozempic is the only way to be sure of the dose.
9. You Are a Non-Responder
In STEP 1, 13.7% of people on semaglutide 2.4 mg lost less than 5% of their body weight after 68 weeks. In the diabetes trials, the share was higher. Genetics, gut hormone differences and the type of obesity all play a role, and researchers cannot yet predict who will respond. Non-response is not a character flaw; it is a known outcome in roughly one in seven people.
What to do: if you have done everything above and lost under 5% after four months at 1 mg or more, you are probably a low responder to semaglutide. Tirzepatide (Zepbound, Mounjaro) works on two hormones instead of one and helps many people who got little from semaglutide; in head-to-head trials it produced about 20% loss versus 14% on Wegovy. There are also non-GLP-1 options. See Ozempic alternatives compared.
Reason-by-Reason Checklist
How to find your reason and what to do
Starting dose
Pen says 0.25 or 0.5 mg
Wait; ask about the next increase
Too early
Under 16 weeks at maintenance dose
Judge at 16 weeks on 1 mg or more
Calories not down
7-day food and drink log
Cut liquid calories, add protein
Alcohol
3 or more drinks a week
4 alcohol-free weeks
Plateau
Lost 10%+, then flat for 3 months
Dose increase, strength training, reassess goal
Missed doses
Gaps over 7 days in the last 2 months
Fixed day, reminders, spare pen
Medications or conditions
Insulin, sulfonylurea, antidepressant, thyroid, PCOS, sleep apnea
Medication review, labs, sleep check
Product quality
Compounded or online source; no effects at all
Switch to pharmacy brand Ozempic
Non-responder
Under 5% lost after 4 months at 1 mg+
Discuss tirzepatide or other options
Does Ozempic Stop Working Over Time?
Not in the sense of the drug failing. What people experience as "stopped working" is usually the plateau described above: the appetite effect becomes your new normal, the body has adapted to a lower weight, and the deficit has closed. The drug is still doing its job of holding weight down; in the trials, people who stopped semaglutide regained about two-thirds of the lost weight within a year, which shows the effect was still active. Our guide to what happens when you stop Ozempic has the numbers.
When to Talk to Your Doctor
- 1You have lost less than 5% of your starting weight after 16 weeks at 1 mg or higher
- 2Weight loss has stopped for three months at 2 mg
- 3Side effects are keeping you on a low dose or making you skip injections
- 4You take insulin, a sulfonylurea, an antidepressant or a steroid and have not had a medication review
- 5You have symptoms of low thyroid (tiredness, cold, constipation), PCOS or sleep apnea
- 6You are gaining weight on Ozempic, which is unusual and worth investigating
Questions to Ask Your Doctor
- 1Am I on the dose you expected me to be on by now, and when is my next increase?
- 2Could any of my other medications be blocking weight loss?
- 3Should we check my thyroid, blood sugar control or sleep?
- 4Is Wegovy at 2.4 mg or 7.2 mg an option, or would tirzepatide suit me better?
- 5Would a dietitian referral be covered by my insurance?
- 6If I am a non-responder, what is the plan?
If the scale is not just flat but actually moving up, the causes overlap but the order of checks is different; see gaining weight on Ozempic for water retention, other medications and the signs that need a doctor.
The Bottom Line
Most people who are not losing weight on Ozempic are either on a starting dose, early in treatment, or eating and drinking more than the appetite signal suggests. Fix those three first. If you are at 1 mg or more for four months with a food log, no regular alcohol and consistent doses, and the scale still has not moved 5%, you may be among the roughly one in seven who respond poorly to semaglutide, and switching drugs is a reasonable next step. Ozempic is a tool, not a verdict; the right dose, the right expectations and the right drug matter more than willpower. For the full picture of what Ozempic can and cannot do for weight, read Ozempic for weight loss and Ozempic vs Wegovy.
FAQ
Because 0.25 mg and 0.5 mg are starting doses meant to reduce nausea while your body adjusts. Most weight loss happens at 1 mg and 2 mg. Ask your doctor about the timing of your next increase.
Appetite can drop while calories stay the same through habit portions, snacking, or liquid calories such as coffee drinks, juice and alcohol, which bypass the fullness effect. A seven-day food and drink log usually finds the gap.
Judge after 16 weeks on a maintenance dose of 1 mg or more, not from your first injection. If you have lost less than 5% by then, talk to your doctor about adjusting the plan or switching drugs.
People with diabetes lose less on semaglutide than people without it, and insulin or sulfonylurea tablets taken alongside it can cause weight gain. Ask whether those doses can be lowered as your blood sugar improves.
About 14% of people lose under 5% on semaglutide. Tirzepatide (Zepbound or Mounjaro) acts on two hormones and often works when semaglutide does not, producing about 20% weight loss in trials. Your doctor can also review non-GLP-1 options.
Sources
- 1Ozempic (semaglutide) injection prescribing information, Novo Nordisk
- 2Wegovy (semaglutide) injection prescribing information, Novo Nordisk
- 3Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), NEJM, 2021
- 4Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2), Lancet, 2021
- 5Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in type 2 diabetes (SUSTAIN FORTE), Lancet Diabetes Endocrinol, 2021
- 6Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension), Diabetes Obes Metab, 2022
- 7Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5), NEJM, 2025
- 8FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. FDA
This article is for general information and is not medical advice. Do not change your dose or stop Ozempic without talking to your doctor.

Dr. Sheri Tomas
Author
Comments (0)
Be the first to comment on this article.




